Free tool
FAERS Monitor: Stribild
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 203100 or its brand name (Stribild, Cobicistat, Elvitegravir, Emtricitabine, Tenofovir Disoproxil Fumarate). Reports on generic versions are filed under their own applications.
Reports
8,967
Serious
7,687
86% of reports
Hospitalization
759
Death reported
144
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- bone density decreased4,603
- renal injury3,312
- skeletal injury3,030
- chronic kidney disease2,519
- tooth loss2,488
- bone loss2,161
- osteonecrosis2,117
- renal failure2,087
- multiple fractures1,980
- tooth injury1,979
- pain1,846
- emotional distress1,813
- osteoporosis1,748
- anxiety1,694
- anhedonia1,636
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2012 | 4 |
| 2013 | 82 |
| 2014 | 373 |
| 2015 | 278 |
| 2016 | 264 |
| 2017 | 231 |
| 2018 | 297 |
| 2019 | 539 |
| 2020 | 3,896 |
| 2021 | 1,444 |
| 2022 | 666 |
| 2023 | 317 |
| 2024 | 280 |
| 2025 | 259 |
| 2026 | 37 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,192 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| tooth injurySignal | 1,979 | 1962.2 | 1855.4 | 2,112,199 |
| skeletal injurySignal | 3,030 | 971.2 | 936.0 | 2,077,504 |
| bone density decreasedSignal | 4,603 | 403.7 | 394.3 | 1,579,577 |
| bone lossSignal | 2,161 | 393.6 | 377.9 | 724,829 |
| multiple fracturesSignal | 1,980 | 321.3 | 308.0 | 556,212 |
| tooth lossSignal | 2,488 | 319.7 | 308.2 | 696,010 |
| renal injurySignal | 3,312 | 294.1 | 285.5 | 860,677 |
| osteonecrosisSignal | 2,117 | 161.5 | 155.4 | 316,305 |
| anhedoniaSignal | 1,636 | 155.6 | 148.7 | 235,873 |
| osteoporosisSignal | 1,748 | 104.1 | 99.7 | 171,080 |
| chronic kidney diseaseSignal | 2,519 | 80.4 | 77.7 | 191,576 |
| renal failureSignal | 2,087 | 37.4 | 36.0 | 73,273 |
| emotional distressSignal | 1,813 | 35.6 | 34.2 | 60,449 |
| anxietySignal | 1,694 | 14.0 | 13.4 | 20,660 |
| painSignal | 1,846 | 7.1 | 6.8 | 9,868 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.